Laboratorios Celsius, founded in 1936, focuses on the production and sale of pharmaceutical specialties and dermocosmetics. In 1996, it acquired Dermur Cosméticos, expanding into the dermocosmetics industry with the same rigor as pharmaceutical products. In 2003, Celsius inaugurated ATGen Diagnóstica, a division related to human health and Molecular Biology, dedicated to manufacturing, importing, and distributing in vitro diagnostic products and supplies. The Uruguayan pharmaceutical market, estimated at $512 million, sees CELSIUS manufacturing about 9 million units annually, covering roughly 8% of the total market and ranking among the top three pharmaceutical companies in the country. Celsius also holds a significant position in the prescription medicine market and is endorsed by the medical community. Its industrial plants are certified by EU experts, crucial for development in pharmaceutical and cosmetic products. With a commitment to sound human resource management, Celsius employs over 300 people, including experienced industry professionals and university graduates. Additionally, Celsius exports its products to various countries in Latin America, the Caribbean, and even Vietnam. Overall, Laboratorios Celsius presents a robust presence in the pharmaceutical industry, catering to the well-being of consumers. Visit its social media page on www.facebook.com/LaboratoriosCelsius.
There is no investment information
No recent news or press coverage available for Laboratorios Celsius.